Internal Medicine, Hematology & Oncology · Columbus, OH
NPI
1457779035
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
410 W 10th Ave
Columbus, OH, 43210
Phone (614) 293-3989
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,016 services
Medicare patients, 2024
162
Average age 72
Drug cost, 2024
$1.9M
696 prescriptions
Company payments, 2025
$23K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathleen C Kerrigan was code 99215 (office e&m - established), 236 times for 103 patients. In total Kathleen C Kerrigan billed 1,016 services in 13 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 236 | 103 | $109.38 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 181 | 79 | $12.73 | $2,304 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 147 | 57 | $24.18 | $3,554 |
| 99215 Office E&M - Established | Office | 104 | 51 | $108.09 | $11K |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 95 | 26 | $23.52 | $2,234 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 90 | 50 | $12.30 | $1,107 |
| 99233 Hospital E&M - Subsequent | Facility | 44 | 27 | $89.76 | $3,950 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 36 | 14 | $21.53 | $775 |
| 99239 Hospital Discharge Management | Facility | 19 | 19 | $88.71 | $1,686 |
| 99205 Office E&M - New | Facility | 19 | 19 | $135.60 | $2,576 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $134.59 | $2,019 |
| 99205 Office E&M - New | Office | 13 | 13 | $121.76 | $1,583 |
By year: 2022 $56K for 577 services; 2023 $38K for 416 services; 2024 $60K for 1,016 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen C Kerrigan prescribed most often to Medicare patients was Levothyroxine Sodium, with 117 prescriptions and refills. In total Kathleen C Kerrigan wrote 696 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 117 | 289 | 43 | $1,271 |
| Ondansetron Hcl Generic | 59 | 59 | 36 | $396 |
| Prochlorperazine Maleate Generic | 47 | 47 | 32 | $675 |
| Eliquis Apixaban | 34 | 39 | 11 | $22K |
| Tafinlar Dabrafenib Mesylate | 31 | 31 | Under 11 | $441K |
| Mekinist Trametinib Dimethyl Sulfoxide | 30 | 30 | Under 11 | $462K |
| Olanzapine Generic | 27 | 31 | Under 11 | $476 |
| Oxycodone Hcl Generic | 22 | 22 | 16 | $609 |
| Xarelto Rivaroxaban | 20 | 24 | Under 11 | $15K |
| Dexamethasone Generic | 20 | 25 | 11 | $278 |
| Potassium Chloride Generic | 19 | 19 | Under 11 | $244 |
| Amlodipine Besylate Generic | 18 | 38 | Under 11 | $52.57 |
| Lorazepam Generic | 17 | 17 | 15 | $64.29 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 15 | 15 | Under 11 | $144 |
| Lenvima Lenvatinib Mesylate | 14 | 14 | Under 11 | $344K |
Brand drugs: 218 claims; generic drugs: 478 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen C Kerrigan $23K ($23K in general payments such as food, travel and fees) from 7 companies. The largest payer was Genentech USA, Inc. with $20K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.